Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTM

Publisher： Karger

E-ISSN： 1660-3818|38|1|19-31

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.38, Iss.1, 2011-01, pp. : 19-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Parvovirus B19 Passive Transmission by Transfusion of Intercept® Blood System-Treated Platelet Concentrate

By  

Transfusion Medicine and Hemotherapy, Vol. 43, Iss. 3, 2016-05 ,pp. : 198-202

Karger

Access to resources Recommend Favorite

Pathogen Inactivation Technologies for Cellular Blood Components: an Update

By  

Transfusion Medicine and Hemotherapy, Vol. 41, Iss. 4, 2014-07 ,pp. : 309-325

Karger

Access to resources Recommend Favorite

Comparison of two platelet transfusion strategies to minimize ABO‐nonidentical transfusion, outdating, and shortages using a computer‐simulated “virtual blood bank”

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 348-356

John Wiley & Sons Inc

Access to resources Recommend Favorite

Presence of medication taken by blood donors in plasma for transfusion

By  

VOX SANGUINIS, Vol. 108, Iss. 4, 2015-05 ,pp. : 323-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Measurement of Thrombin in Different Matrices: Whole Blood, Platelet-Rich and Platelet-Poor Plasma Using Fluorogenic Substrate ZGGR-AMC

By  

Acta Haematologica, Vol. 130, Iss. 3, 2013-05 ,pp. : 150-152

Karger

Access to resources Recommend Favorite